Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAAGA vs Azelastine in Allergic Conjunctivitis with Tear Film Dysfunction
NCT06800274Phase 4Completed
- Sponsor
- San Giovanni di Dio e Ruggi d'Aragona
- Start
- Apr 2023
- Primary completion
- Mar 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spaglumic acid in allergic conjunctivitis (AC), dry eye disease (DED), sponsored by San Giovanni di Dio e Ruggi d'Aragona. Started Apr 2023; status: completed.
02
Drugs
spaglumic acid
03
Conditions
allergic conjunctivitis (AC)dry eye disease (DED)
Beyond the preview
Go deeper on NCT06800274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06800274.